the largest number multi-drug resistant TB cases that constitute 43 % of global cases . MedGenome ’ s SPIT- SEQ test sequences the whole genome of Mycobacterium Tuberculosis ( Mtb ) from the sputum of patients suffering from tuberculosis . The existing molecular techniques have a limitation of covering only a few drugs . Our test covers all drug resistance markers – reported as well as novel . The use of sputum eliminates the requirement of growing a culture and hence reduces the time delay in diagnosis and can be used for strain typing , epidemiology studies and disease surveillance .
Future Outlook
The ever increasing public interest in personalized medicine and genetic testing have contributed to the growth potential of genomics companies like MedGenome . As awareness of the importance of understanding genetic predispositions to diseases and optimizing treatments grows , so does the demand for genomics services and products . Moreover , collaborations with research institutions , healthcare providers , and biotech firms can expand the reach and impact of the company , fostering innovation and driving market growth .
As genomics moves towards democratization , strengthening local presence is crucial for the company and it plans to do substantial investments in this domain . MedGenome ’ s strategic approach involves an expanded geographical footprint beyond India while intensifying its domestic network . With the rapid pace of technological innovation and the expanding applications of genomics across diverse sectors , the company is looking at expanding globally as it is inclined towards building its research services portfolio to enable drug discovery for a wide range of diseases .
“ We will continue to build more research partnerships in India with hospitals and scientific institutions . These engagements are rooted in research and academic collaborations with a focus on practical applications . In terms of our products , we are very optimistic about the role of genomics in liquid biopsy , TB and the preventive wellness tests in bringing positive outcomes for the patients ,” says Pratapneni while outlining the key priorities .
BIOVOICENEWS . COM 25